Low Grade Serous Carcinoma clinical trials at University of California Health
1 research study open to eligible people
open to eligible females ages 18 years and up
The study evaluates the response to treatment with Ribociclib and Letrozole in patients with low grade serous cancer of the ovary, fallopian tube or peritoneum.
Our lead scientists for Low Grade Serous Carcinoma research studies include Lee-may Chen, MD.